Your browser doesn't support javascript.
Collaborated effort against SARS-CoV-2 outbreak in China.
Yang, Qiwen; Zhou, Yang; Ai, Jingwen; Ma, Jinmin; Cao, Fenglin; Cao, Weifan; Zhang, Wengeng; Wang, Shifu; Chen, Weijun; Ma, Xiaoling; Zhang, Wenhong; Li, Weimin.
  • Yang Q; Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Zhou Y; BGI PathoGenesis Pharmaceutical Technology Co., Ltd, BGI-Shenzhen, Shenzhen, China.
  • Ai J; Department of Infectious Disease, Huashan Hospital of Fudan University, Shanghai, China.
  • Ma J; BGI-Shenzhen, Shenzhen, China.
  • Cao F; The Centre Laboratory of Hematological and Oncological, Department, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Cao W; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong.
  • Zhang W; Precision Medicine Center & Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China.
  • Wang S; Department of Children's Medical Laboratory Diagnosis Center, Qilu Children's Hospital of Shandong University, Jinan, China.
  • Chen W; BGI PathoGenesis Pharmaceutical Technology Co., Ltd, BGI-Shenzhen, Shenzhen, China.
  • Ma X; BGI-Shenzhen, Shenzhen, China.
  • Zhang W; Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.
  • Li W; Department of Infectious Disease, Huashan Hospital of Fudan University, Shanghai, China.
Clin Transl Med ; 10(1): 13-16, 2020 Jan.
Article in English | MEDLINE | ID: covidwho-847850
ABSTRACT
A previously unknown beta coronavirus, SARS-CoV-2, was discovered from a cluster of patients with pneumonia of unknown cause in Wuhan since the end of 2019. Ever since the start of COVID-19, government administrations, academic institutions, and technology enterprises are under unprecedented cooperation in controlling this outbreak from pathogen identification, epidemic situation assessment, to outbreak containment. Timely identification, isolation, and whole-genome sequencing of SARS-CoV-2 have laid the foundation for effective control of this novel infection. With the increasing case numbers worldwide, more real-time information is emerging, changing our understandings to SARS-CoV-2 outbreak, and nonetheless refining the outbreak control responses. The efficient management of COVID-19 requires global collaboration and an efficient share of information.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Language: English Journal: Clin Transl Med Year: 2020 Document Type: Article Affiliation country: Ctm2.7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Language: English Journal: Clin Transl Med Year: 2020 Document Type: Article Affiliation country: Ctm2.7